drugset / Trial / NCT02613117

Research on Oral Tolerability and Product Application/Response of Two Oxalate Products for Dental Patients With Risk of Dentinal Hypersensitivity

NCT02613117

Completed 104 enrolled Procter and Gamble
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will assess the oral tolerability and immediate post-treatment safety of topical application for two marketed oxalate products as initial care in dental patients to treat or prevent tooth sensitivity pain that may be attributed to dentinal hypersensitivity.

Timeline

Start
2015-11
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Background stannous fluoride Small molecule

Indications